| Quarterly Financials | Jun 2015 | Sept 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sept 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sept 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 |
Revenue  | 56 | 63 | 55 | 67 | 72 | 81 | 74 | 89 | 93 | 92 | 88 | 108 | 99 | 107 | 100 | 108 | 112 | 119 | 107 | 104 | 58 | 158 | 141 | 151 | 175 | 191 | 119 | 133 | 129 | 137 | 131 | 140 | 136 | 151 | 138 | 158 | 161 | 180 | 170 | 192 | 198 | 220 |
| Expenses | 37 | 36 | 35 | 41 | 42 | 64 | 51 | 60 | 53 | 53 | 49 | 60 | 56 | 61 | 61 | 71 | 64 | 64 | 62 | 77 | 48 | 91 | 89 | 95 | 94 | 87 | 81 | 93 | 92 | 103 | 100 | 111 | 100 | 111 | 103 | 121 | 115 | 129 | 124 | 130 | 135 | 145 |
| EBITDA | 20 | 26 | 20 | 27 | 30 | 17 | 23 | 30 | 39 | 39 | 39 | 48 | 43 | 46 | 39 | 37 | 48 | 55 | 45 | 26 | 9 | 67 | 52 | 55 | 81 | 104 | 38 | 40 | 37 | 33 | 31 | 29 | 36 | 40 | 35 | 37 | 46 | 51 | 46 | 62 | 63 | 75 |
| Operating Profit % | 34 % | 39 % | 36 % | 38 % | 39 % | 18 % | 28 % | 32 % | 39 % | 40 % | 42 % | 39 % | 42 % | 41 % | 37 % | 33 % | 42 % | 45 % | 41 % | 24 % | 15 % | 40 % | 36 % | 35 % | 43 % | 51 % | 31 % | 29 % | 28 % | 23 % | 22 % | 18 % | 26 % | 25 % | 23 % | 22 % | 27 % | 27 % | 25 % | 30 % | 30 % | 33 % |
| Depreciation | 5 | 4 | 5 | 5 | 4 | 4 | 5 | 5 | 4 | 5 | 5 | 6 | 6 | 7 | 7 | 7 | 7 | 8 | 8 | 9 | 7 | 8 | 8 | 8 | 7 | 8 | 9 | 10 | 9 | 9 | 10 | 11 | 10 | 11 | 14 | 13 | 11 | 13 | 17 | 14 | 11 | 12 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | -0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit Before Tax | 17 | 25 | 19 | 22 | 26 | 13 | 19 | 25 | 35 | 34 | 34 | 42 | 38 | 39 | 32 | 29 | 40 | 46 | 37 | 18 | 2 | 59 | 44 | 48 | 74 | 95 | 29 | 30 | 28 | 24 | 20 | 17 | 25 | 28 | 20 | 23 | 34 | 37 | 28 | 47 | 51 | 63 |
| Tax | 6 | 9 | 8 | 8 | 9 | 11 | 9 | 9 | 13 | 10 | 12 | 17 | 14 | 14 | 12 | 13 | 13 | 11 | 9 | 19 | 2 | 16 | 12 | 10 | 18 | 18 | 7 | 9 | 6 | 8 | 5 | 5 | 8 | 8 | 5 | 6 | 10 | 10 | 9 | 26 | 12 | 15 |
| Net Profit | 11 | 16 | 11 | 14 | 17 | 1 | 9 | 15 | 22 | 25 | 22 | 25 | 23 | 25 | 20 | 16 | 28 | 35 | 28 | -2 | 0 | 43 | 32 | 38 | 56 | 78 | 22 | 21 | 22 | 15 | 15 | 13 | 17 | 20 | 15 | 17 | 24 | 26 | 19 | 22 | 38 | 48 |
| EPS in ₹ | 2.33 | 3.28 | 2.13 | 2.71 | 3.18 | 0.22 | 1.71 | 2.90 | 4.10 | 4.59 | 4.03 | 4.68 | 4.35 | 4.70 | 3.81 | 3.09 | 5.20 | 6.73 | 5.21 | -0.30 | 0.04 | 8.15 | 6.13 | 7.14 | 10.51 | 14.70 | 4.05 | 4.04 | 4.11 | 3.80 | 2.78 | 2.36 | 3.26 | 3.84 | 2.78 | 3.54 | 4.52 | 4.99 | 3.58 | 4.17 | 7.35 | 9.05 |
Thyrocare Technologies
Thyrocare Technologies
1,350.60
+20.30
(1.53%)
There are new updates from the company1 day ago
View
Key Fundamentals
Market Cap
7,049.90 Cr
EPS
17.13
PE Ratio
55.73
Dividend Yield
1.58 %
Industry
Healthcare Services 52 Week High
1,474.00
52 Week Low
658.00
PB Ratio
13.21
Debt to Equity
0.06
Sector
Healthcare Service Provider Analyst Rating and Forecast
- By Refinitiv from2 analysts
Actual
Company News
View All News
Docon Technologies Private Limited, a wholly owned subsidiary of API Holdings Limited and promoter of Thyrocare Technologies Limited, sold 53,32,860 equity shares representing approximately 10% of Thyrocare's total paid-up share capital. The transaction was completed on October 24, 2025 through market trades. Following this sale, Docon's promoter shareholding in Thyrocare decreased from 70.98% to 60.93% of the total paid-up equity share capital. Docon continues to remain a promoter and holding company of Thyrocare after the transaction. The disclosure was made under regulatory requirements to stock exchanges BSE Limited and National Stock Exchange of India Limited.
ICICI Prudential Mutual Fund acquired 19,98,400 shares of Thyrocare Technologies on October 24, 2025, through secondary market purchases. This acquisition increased the fund's total shareholding from 8,25,490 shares (1.56%) to 28,23,890 shares (5.33%) of the company's paid-up capital. The fund clarified that the holding is from an investment perspective and not aimed at seeking controlling interest. Thyrocare Technologies has a total equity share capital of ₹52,99,44,470 comprising 5,29,94,447 shares with a face value of ₹10 each. The company's shares are listed on BSE Limited and National Stock Exchange of India Limited.
Docon Technologies Private Limited, a promoter of Thyrocare Technologies Limited, sold 53,32,860 equity shares representing approximately 10% of the company's total paid-up capital through market trades on October 24, 2025. The transaction was executed at an average price of Rs 1,252.03 per share for a total consideration of Rs 667.69 crore. Following this sale, Docon remains a promoter of the company, with the overall promoter shareholding decreasing from 70.98% to 60.93%.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
3,089.60 | #1 25,900.90 | 49.89 | #1 2,554.80 | 11.28 | #1 492 | 24.30 | 44.69 | |
1,007.15 | 10,271.50 | 68.07 | 699.70 | 23.06 | 144 | 22.54 | 50.32 | |
1,944.80 | 10,071.90 | 66.10 | 1,346.30 | 10.64 | 146 | 18.90 | 42.56 | |
1,350.60 | #4 7,049.90 | #7 55.73 | #5 702.20 | #4 20.80 | #4 91 | #2 81.06 | 66.95 | |
791.30 | 2,581.00 | 32.23 | 742.70 | 16.70 | 78 | 14.53 | 44.40 | |
323.00 | 1,681.40 | 51.54 | 255.90 | 15.11 | 31 | 19.48 | 66.94 | |
1,374.00 | 1,137.40 | 23.19 | 111.60 | 28.72 | 48 | 11.50 | 46.91 | |
302.05 | 954.00 | #1 -6.43 | 1,170.80 | -18.47 | -134 | -35.12 | 46.90 | |
360.00 | 672.80 | 25.33 | 147.80 | #1 134.60 | 19 | #1 444.44 | 68.63 | |
145.10 | 99.80 | 66.94 | 41.80 | 13.28 | 2 | 0.00 | 26.71 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
20.80 %
Net Income Growth
30.65 %
Cash Flow Change
14.13 %
ROE
25.97 %
ROCE
43.70 %
EBITDA Margin (Avg.)
15.68 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 329 | 410 | 438 | 479 | 475 | 471 | 546 | 608 | 633 | 644 | 693 |
| Fixed Assets | 196 | 259 | 259 | 299 | 294 | 269 | 253 | 285 | 294 | 306 | 297 |
| Current Assets | 111 | 134 | 150 | 142 | 136 | 152 | 240 | 270 | 273 | 279 | 338 |
| Capital Work in Progress | 6 | 1 | 17 | 0 | 2 | 5 | 8 | 3 | 2 | 3 | 14 |
| Investments | 84 | 92 | 104 | 120 | 95 | 90 | 126 | 146 | 144 | 162 | 162 |
| Other Assets | 43 | 58 | 58 | 60 | 84 | 107 | 159 | 174 | 193 | 173 | 220 |
| Total Liabilities | 329 | 410 | 438 | 479 | 475 | 471 | 546 | 608 | 633 | 644 | 693 |
| Current Liabilities | 7 | 31 | 18 | 20 | 21 | 82 | 95 | 65 | 77 | 91 | 122 |
| Non Current Liabilities | 10 | 13 | 12 | 15 | 19 | 23 | 23 | 17 | 20 | 26 | 24 |
| Total Equity | 312 | 366 | 408 | 443 | 435 | 367 | 427 | 527 | 535 | 528 | 547 |
| Reserve & Surplus | 226 | 312 | 354 | 390 | 382 | 314 | 374 | 474 | 463 | 440 | 439 |
| Share Capital | 51 | 54 | 54 | 54 | 53 | 53 | 53 | 53 | 53 | 53 | 53 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | -6 | 5 | -1 | -0 | -5 | 4 | 5 | 0 | 4 | -9 | 8 |
| Investing Activities | -18 | -18 | -42 | -43 | -12 | 1 | -49 | -24 | -39 | -91 | -53 |
| Operating Activities | 35 | 68 | 90 | 107 | 100 | 168 | 115 | 113 | 129 | 168 | 191 |
| Financing Activities | -23 | -45 | -49 | -64 | -94 | -165 | -62 | -89 | -86 | -85 | -130 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 |
| Promoter | 66.14 % | 66.14 % | 71.22 % | 71.18 % | 71.18 % | 71.18 % | 71.14 % | 71.14 % | 71.14 % | 71.14 % | 71.14 % | 71.11 % | 71.11 % | 71.11 % | 71.11 % | 71.06 % | 71.06 % | 71.06 % | 71.06 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 3.46 % | 0.00 % | 2.90 % | 2.49 % | 1.93 % | 2.77 % | 2.41 % | 3.23 % | 4.85 % |
| DIIs | 7.14 % | 6.17 % | 6.07 % | 6.37 % | 6.52 % | 6.68 % | 8.66 % | 8.69 % | 8.45 % | 13.46 % | 13.33 % | 13.55 % | 14.88 % | 14.90 % | 14.80 % | 14.67 % | 14.97 % | 14.54 % | 13.47 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 5.01 % | 6.32 % | 7.60 % | 7.44 % | 6.65 % | 6.71 % | 7.28 % | 8.07 % | 8.38 % | 9.42 % | 9.66 % | 9.15 % | 8.48 % | 8.66 % | 9.78 % | 9.16 % | 9.21 % | 8.94 % | 8.19 % |
| Others | 21.71 % | 21.37 % | 15.11 % | 15.01 % | 15.66 % | 15.43 % | 12.91 % | 12.10 % | 12.03 % | 5.97 % | 2.42 % | 6.19 % | 2.63 % | 2.84 % | 2.38 % | 2.33 % | 2.36 % | 2.23 % | 2.43 % |
| No of Share Holders | 0 | 44,722 | 53,140 | 62,936 | 65,769 | 66,315 | 66,431 | 71,412 | 74,386 | 76,292 | 72,000 | 68,844 | 64,823 | 61,636 | 59,377 | 56,666 | 57,403 | 54,566 | 54,142 |
Dividend History
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 10 | 10 | 20 | 5 | 25 | 15 | 18 | 18 | 21 |
| Dividend Yield (%) | 0.00 | 1.68 | 1.87 | 4.03 | 0.55 | 3.22 | 3.56 | 3.05 | 2.65 | 1.58 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 19 Jun 2021 |  Dividend | ₹ 15.00 /share | 17 Jun 2021 | 1,059.45 | 1,287.65 |
| 12 May 2022 | Dividend | ₹ 15.00 /share | 11 May 2022 | 812.25 | 736.75 |
| 20 Apr 2023 | Dividend | ₹ 18.00 /share | 20 Apr 2023 | 446.85 | 504.70 |
| 16 Aug 2024 | Dividend | ₹ 18.00 /share | 16 Aug 2024 | 619.25 | 879.70 |
| 23 Aug 2024 |  Annual General Meeting | NA | 23 Aug 2024 | 818.05 | 892.80 |
| 23 Oct 2024 |  Quarterly Result Announcement | NA | 23 Oct 2024 | 828.55 | 886.45 |
| 23 Jan 2025 | Quarterly Result Announcement | NA | 23 Jan 2025 | 827.90 | 806.35 |
| 23 Apr 2025 | Quarterly Result Announcement | NA | 23 Apr 2025 | 701.65 | 794.30 |
| 23 Jul 2025 | Quarterly Result Announcement | NA | 23 Jul 2025 | 1,164.70 | 1,186.65 |
| 25 Jul 2025 | Dividend | ₹ 21.00 /share | 25 Jul 2025 | 794.30 | 1,338.30 |
| 31 Jul 2025 | Annual General Meeting | NA | 31 Jul 2025 | 1,020.40 | 1,299.60 |
| 14 Oct 2025 | Quarterly Result Announcement | NA | 14 Oct 2025 | 1,179.30 | 1,263.10 |
| 24 Oct 2025 | Dividend | ₹ 7.00 /share | 24 Oct 2025 | 1,263.10 | 1,251.90 |
Announcements
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
1 day ago
1 day agoDisclosures under Reg. 29(1) of SEBI (SAST) Regulations 20112 days ago
2 days agoDisclosure Of Sale Of 5332860 Equity Shares (Approximately 10% Stake) By Promoter - Docon Technologies Private Limited5 days ago
5 days agoAnnouncement under Regulation 30 (LODR)-Earnings Call TranscriptOct 17, 2025
Oct 17, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 17, 2025
Oct 17, 2025Shareholder Meeting / Postal Ballot-Notice of Postal BallotOct 16, 2025
Oct 16, 2025Shareholder Meeting / Postal Ballot-Notice of Postal BallotOct 16, 2025
Oct 16, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 15, 2025
Oct 15, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeOct 14, 2025
Oct 14, 2025Corporate Action-Board recommends Bonus IssueOct 14, 2025
Oct 14, 2025Record Date For Purpose Of Interim DividendOct 14, 2025
Oct 14, 2025Corporate Action-Board approves DividendOct 14, 2025
Oct 14, 2025Re-Appointment Of Internal AuditorOct 14, 2025
Oct 14, 2025Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSOct 14, 2025
Oct 14, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseOct 14, 2025
Oct 14, 2025Announcement under Regulation 30 (LODR)-Investor PresentationOct 14, 2025
Oct 14, 2025Financial Results For The Quarter And Half Year Ended September 30 2025.Oct 14, 2025
Oct 14, 2025Board Meeting Outcome for Outcome Of The Board Meeting Held On October 14 2025Oct 14, 2025
Oct 14, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 08, 2025
Oct 08, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationOct 06, 2025
Oct 06, 2025Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025 Declaration Of Interim Dividend And Proposal For Issue Of Bonus Shares.Oct 06, 2025
Oct 06, 2025 Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportSep 26, 2025
Sep 26, 2025Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotSep 26, 2025
Sep 26, 2025Closure of Trading WindowSep 26, 2025
Sep 26, 2025Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Sep 24, 2025
Sep 24, 2025Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011.Sep 24, 2025
Sep 24, 2025Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Sep 24, 2025
Sep 24, 2025Grant Of Employee Stock Options Under Thyrocare Employee Stock Option Scheme.Sep 23, 2025
Sep 23, 2025Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011Sep 19, 2025
Sep 19, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Sep 19, 2025
Sep 19, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Sep 19, 2025
Sep 19, 2025Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Sep 19, 2025
Sep 19, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Sep 18, 2025
Sep 18, 2025Disclosure under Regulation 30A of LODRSep 15, 2025
Sep 15, 2025Disclosure under Regulation 30A of LODRSep 15, 2025
Sep 15, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 26, 2025
Aug 26, 2025Shareholder Meeting / Postal Ballot-Notice of Postal BallotAug 25, 2025
Aug 25, 2025Thyrocare Technologies Limited Has Informed The Exchange About Intimation Regarding The Appointment Of Mr. Rahul Guha As Managing Director And Chief Executive Officer Of API Holdings Limited Ultimate Holding Company In Addition To His Current Position Of Aug 06, 2025
Aug 06, 2025Intimation Regarding The Appointment Of Mr. Rahul Guha Managing Director And Chief Executive Officer Of The Company As Managing Director And Chief Executive Officer Of API Holdings Limited Ultimate Holding CompanyAug 06, 2025
Aug 06, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportJul 31, 2025
Jul 31, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMJul 31, 2025
Jul 31, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptJul 28, 2025
Jul 28, 2025General UpdateJul 24, 2025
Jul 24, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 24, 2025
Jul 24, 2025Audio Recordings Of Earnings Conference Call For The Quarter Ended June 30 2025. Jul 23, 2025
Jul 23, 2025Announcement under Regulation 30 (LODR)-Change in ManagementJul 23, 2025
Jul 23, 2025Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015Jul 23, 2025
Jul 23, 2025Announcement under Regulation 30 (LODR)-Change in ManagementJul 23, 2025
Jul 23, 2025Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)Jul 23, 2025
Jul 23, 2025Announcement under Regulation 30 (LODR)-Change in DirectorateJul 23, 2025
Jul 23, 2025Mutual Fund Holdings
Nippon India Pharma Fund Direct-Growth 
ICICI Prudential India Opportunities Fund Direct - Growth 
Motilal Oswal Nifty Microcap 250 Index Fund Direct - Growth 
WhiteOak Capital Pharma and Healthcare Fund Direct - Growth 
Aditya Birla Sun Life Bal Bhavishya Yojna Direct-Growth 
Shriram Multi Sector Rotation Fund Direct-Growth 
ICICI Prudential Active Momentum Fund Direct-Growth 
DSP India T.I.G.E.R. (The Infrastructure Growth and Economic Reforms Fund) Direct-Growth 
Groww Nifty Total Market Index Fund Direct - Growth 
Angel One Nifty Total Market Index Fund Direct - Growth 
Mirae Asset Nifty Total Market Index Fund Direct-Growth 
Bandhan Nifty Total Market Index Fund Direct-Growth 
HDFC Pharma And Healthcare Fund Direct - Growth 
Quant ESG Integration Strategy Fund Direct - Growth Technical Indicators
RSI(14)
Neutral 64.57
ATR(14)
Volatile 56.01
STOCH(9,6)
Neutral 26.08
STOCH RSI(14)
Overbought 92.90
MACD(12,26)
Bullish 10.19
ADX(14)
Strong Trend 36.30
UO(9)
Bearish 46.47
ROC(12)
Uptrend And Accelerating 10.25
WillR(14)
Neutral -51.51
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
